1. Home
  2. GHRS vs THFF Comparison

GHRS vs THFF Comparison

Compare GHRS & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • THFF
  • Stock Information
  • Founded
  • GHRS 2018
  • THFF 1984
  • Country
  • GHRS Ireland
  • THFF United States
  • Employees
  • GHRS N/A
  • THFF N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • THFF Major Banks
  • Sector
  • GHRS Health Care
  • THFF Finance
  • Exchange
  • GHRS Nasdaq
  • THFF Nasdaq
  • Market Cap
  • GHRS 774.1M
  • THFF 699.2M
  • IPO Year
  • GHRS 2021
  • THFF N/A
  • Fundamental
  • Price
  • GHRS $11.94
  • THFF $58.35
  • Analyst Decision
  • GHRS Strong Buy
  • THFF Buy
  • Analyst Count
  • GHRS 8
  • THFF 3
  • Target Price
  • GHRS $30.63
  • THFF $59.50
  • AVG Volume (30 Days)
  • GHRS 190.5K
  • THFF 49.6K
  • Earning Date
  • GHRS 11-13-2025
  • THFF 10-21-2025
  • Dividend Yield
  • GHRS N/A
  • THFF 3.50%
  • EPS Growth
  • GHRS N/A
  • THFF 21.43
  • EPS
  • GHRS N/A
  • THFF 5.24
  • Revenue
  • GHRS N/A
  • THFF $230,446,000.00
  • Revenue This Year
  • GHRS N/A
  • THFF $30.73
  • Revenue Next Year
  • GHRS N/A
  • THFF $2.82
  • P/E Ratio
  • GHRS N/A
  • THFF $11.14
  • Revenue Growth
  • GHRS N/A
  • THFF 19.59
  • 52 Week Low
  • GHRS $6.00
  • THFF $40.57
  • 52 Week High
  • GHRS $20.50
  • THFF $60.77
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 34.28
  • THFF 56.22
  • Support Level
  • GHRS $13.71
  • THFF $57.67
  • Resistance Level
  • GHRS $14.59
  • THFF $59.07
  • Average True Range (ATR)
  • GHRS 0.76
  • THFF 0.98
  • MACD
  • GHRS -0.12
  • THFF -0.13
  • Stochastic Oscillator
  • GHRS 3.99
  • THFF 21.94

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

Share on Social Networks: